Effective from 2nd March 2026
We have maintained the prices of the ALLSKIN | MED range for the last 3 years, but, as we know, cost pressures are all around us, and the manufacturing and raw material costs of ALLSKIN | MED have been and continue to be affected by them. In addition, we have a sophisticated new retinoid combination technology that is updating the ALLSKIN | MED Renewal Serum range. This will also be an exciting new dermatological ingredient in upcoming formulations. This technological advance is also affecting costs.
As a result, we need to implement an ALLSKIN | MED price increase for specific products. This is an advance notice; it will not take effect until the 2nd of March 2026. The updated price list is being prepared, and your AesthetiCare Clinic Development Manager will work through it with you in the near future.
We recognise that clinics continue to operate in a challenging environment, with ongoing cost pressures across the industry. This price update is the result of a careful, product-by-product review rather than a blanket increase across the range. When you review it, you will see that changes have been implemented only where necessary, and that where an increase was not required, pricing has been maintained. Any price increases have also been reflected in the suggested selling price (SRP), ensuring your clinic’s margins are maintained.
This adjustment reflects Cantabria Labs’ continued commitment to research, development, and innovation, ensuring that ALLSKIN | MED continues to deliver clinically robust, evidence-based solutions for professional skin clinics. 2026 is an exciting year for ALLSKIN | MED, with an extensive programme of new product development, education, content, and added-value initiatives planned to support patient outcomes, retail performance, and long-term clinic growth.
If you would like to speak to your Clinic Development Manager about this change, you can contact them directly or complete the form below to arrange a callback.